01
Cash & equivalents decreased 31.8%
Cash & equivalents changed -31.8% from the comparable as-filed period.
$6.5M→$4.4MComparable → current
· Pharmaceutical Preparations
RESEARCH SNAPSHOTACTUATE THERAPEUTICS, INC.'s latest supported as-filed period reports net income of -$4.9M, 18.2% above the comparable as-filed period. Every value below links to its SEC accession and metric lineage.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
Cash & equivalents changed -31.8% from the comparable as-filed period.
Net income changed +18.2% from the comparable as-filed period.
Operating income changed +17.8% from the comparable as-filed period.
Research & development changed -25.2% from the comparable as-filed period.
Each point keeps the date investors could first observe it and its accession.
ACTU · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001683168-26-006493SEC ↗10-QAug 14, 2026Period Jun 30, 20260001683168-26-006472SEC ↗8-KJul 17, 2026Period Jul 15, 20260001683168-26-005616SEC ↗8-KMay 22, 2026Period May 21, 20260001683168-26-004268SEC ↗4May 22, 2026Period May 21, 20260001683168-26-004260SEC ↗4May 22, 2026Period May 21, 20260001683168-26-004257SEC ↗4May 22, 2026Period May 21, 20260001683168-26-004255SEC ↗Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
| Filed / transacted | Reporting owner | Semantics | Shares | Price | Notional | Source |
|---|---|---|---|---|---|---|
| Aug 14, 2026Filed Aug 14, 2026 | SCHMITT DANIEL MPresident, CEO and Director | Option ExerciseDirect | 272,056 | $0 | $0 | Form 4 ↗ |
| Aug 14, 2026Filed Aug 14, 2026 | SCHMITT DANIEL MPresident, CEO and Director | Tax WithholdingDirect | 120,521 | $1 | $121,726 | Form 4 ↗ |
| Aug 14, 2026Filed Aug 14, 2026 | SCHMITT DANIEL MPresident, CEO and Director | Option ExerciseDirect | 272,056 | $0 | $0 | Form 4 ↗ |
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Stock-based compensation changed -15.1% from the comparable as-filed period.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-06-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001683168-26-004251